» Articles » PMID: 35980380

Genomic Tools for Health: Secondary Findings As Findings to Be Shared

Overview
Journal Genet Med
Publisher Elsevier
Specialty Genetics
Date 2022 Aug 18
PMID 35980380
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Whether and how to disclose secondary finding (SF) information to children is ethically debated. Some argue that genetic testing of minors should be limited to preserve the child's future autonomy. Others suggest that disclosure of SFs can occur if it is in the best interests of the child. However, the ways that parents conceptualize and weigh their child's future autonomy against the interests of their child and other family members are unknown.

Methods: To explore how parents understand SF disclosure in the context of their child and other family members' lives, we conducted semistructured interviews with 30 families (40 parents in total). All parents had children who were enrolled in a genetic sequencing protocol that returned results by default.

Results: We found that parents did not routinely conceptualize SFs as distinctive health information. Rather parents saw this information as part of their child's overall health. To make decisions about disclosure, parents weighed their child's ability to understand the SF information and their other family member's need to know.

Conclusion: Because most families desired SF information, we argue that disclosure of SF be reconceptualized to reflect the lived experiences of those who may receive this information.

Citing Articles

Clinically actionable incidental and secondary parental genomic findings after proband exome sequencing: Yield and dilemmas.

Basel-Salmon L, Ruhrman-Shahar N, Orenstein N, Levy M, Lidzbarsky G, Batzir N Genet Med Open. 2024; 1(1):100813.

PMID: 39669250 PMC: 11613716. DOI: 10.1016/j.gimo.2023.100813.


Factors affecting couples' decision making about expanded prenatal cell-free DNA screening.

Mumford K, Hendriks S, Miner S, Huelsnitz C, Wakim P, Berkman B Genet Med Open. 2024; 2.

PMID: 39634380 PMC: 11613822. DOI: 10.1016/j.gimo.2024.101890.


Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study.

Kim Y, Kim J, Cho H, Park H, Park M Hum Genet. 2023; 142(11):1561-1569.

PMID: 37728764 PMC: 10602966. DOI: 10.1007/s00439-023-02592-8.


Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project.

Green R, Shah N, Genetti C, Yu T, Zettler B, Uveges M Am J Hum Genet. 2023; 110(7):1034-1045.

PMID: 37279760 PMC: 10357495. DOI: 10.1016/j.ajhg.2023.05.007.


Framing the Family: A Qualitative Exploration of Factors That Shape Family-Level Experience of Pediatric Genomic Sequencing.

Smith H, Bonkowski E, Hickingbotham M, Deloge R, Pereira S Children (Basel). 2023; 10(5).

PMID: 37238322 PMC: 10217651. DOI: 10.3390/children10050774.


References
1.
Meiser B, Gleeson M, Tucker K . Psychological impact of genetic testing for adult-onset disorders. An update for clinicians. Med J Aust. 2000; 172(3):126-9. View

2.
Parker M . Genetic testing in children and young people. Fam Cancer. 2009; 9(1):15-8. DOI: 10.1007/s10689-009-9272-6. View

3.
McGowan M, Prows C, DeJonckheere M, Brinkman W, Vaughn L, Myers M . Adolescent and Parental Attitudes About Return of Genomic Research Results: Focus Group Findings Regarding Decisional Preferences. J Empir Res Hum Res Ethics. 2018; 13(4):371-382. PMC: 6146016. DOI: 10.1177/1556264618776613. View

4.
Miller D, Lee K, Chung W, Gordon A, Herman G, Klein T . ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021; 23(8):1381-1390. DOI: 10.1038/s41436-021-01172-3. View

5.
Mand C, Gillam L, Duncan R, Delatycki M . "It was the missing piece": adolescent experiences of predictive genetic testing for adult-onset conditions. Genet Med. 2013; 15(8):643-9. DOI: 10.1038/gim.2013.15. View